Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOSTARLIMAB-GXLY: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

92.7%
Female
7.3%
Male

Age Information

The average age of patients reporting adverse events with DOSTARLIMAB-GXLY is 67.4 years.

Geographic Distribution

The majority of adverse event reports for DOSTARLIMAB-GXLY originate from US.

Report Summary & Outcomes

504
Total Reports
504
As Primary/Secondary Suspect
55
Deaths Reported
126
Hospitalizations
26
Life-Threatening
3
Disabilities

Reporting Timeline

First adverse event report: 20210816. Most recent report: 20250903. View full timeline →

More About DOSTARLIMAB-GXLY

DOSTARLIMAB-GXLY Full Profile Reports by Year Drug Interactions